Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. (Q51020521)
Jump to navigation
Jump to search
scientific article published in February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. |
scientific article published in February 2004 |
Statements
Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. (English)
1 reference
1 reference
Julinda Mehilli
1 reference
Albert Schömig
1 reference
Adnan Kastrati
1 reference
Klaus Schlotterbeck
1 reference
Franz Dotzer
1 reference
Josef Dirschinger
1 reference
Claus Schmitt
1 reference
Melchior Seyfarth
1 reference
Stefan Martinoff
1 reference
Christina Markwardt
1 reference
Günther Clermont
1 reference
Hans-Wilhelm Gerbig
1 reference
Johannes Leiss
1 reference
Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators
1 reference
1 February 2004
1 reference
291
1 reference
8
1 reference
947-954
1 reference
Identifiers
1 reference